TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $430,390 | +41.1% | 27,821 | +43.3% | 0.04% | +52.0% |
| Q2 2023 | $305,010 | -12.9% | 19,415 | -8.6% | 0.02% | -21.9% |
| Q1 2023 | $350,168 | +73.4% | 21,248 | +64.2% | 0.03% | +60.0% |
| Q4 2022 | $201,925 | -37.7% | 12,944 | -48.2% | 0.02% | -41.2% |
| Q3 2022 | $324,000 | +105.1% | 24,985 | +120.8% | 0.03% | +112.5% |
| Q2 2022 | $158,000 | -46.1% | 11,314 | -44.6% | 0.02% | -38.5% |
| Q1 2022 | $293,000 | +23.6% | 20,424 | +17.8% | 0.03% | +30.0% |
| Q4 2021 | $237,000 | -16.8% | 17,338 | -0.4% | 0.02% | -23.1% |
| Q3 2021 | $285,000 | +7.5% | 17,400 | +10.6% | 0.03% | +4.0% |
| Q2 2021 | $265,000 | -15.1% | 15,730 | -7.9% | 0.02% | -19.4% |
| Q1 2021 | $312,000 | +16.4% | 17,073 | +15.9% | 0.03% | 0.0% |
| Q4 2020 | $268,000 | -8.8% | 14,732 | -10.5% | 0.03% | -20.5% |
| Q3 2020 | $294,000 | +12.2% | 16,452 | +12.6% | 0.04% | +5.4% |
| Q2 2020 | $262,000 | – | 14,610 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |